4don MSN
'Clinical oversight can lead to…': Govt lists side-effects that can occur from weight-loss drugs
In India, only endocrinologists, internal medicine specialists, and cardiologists can prescribe GLP-1 weight loss drugs.
India warns of GLP-1 drug risks as Ozempic and Wegovy prices fall, urging prescription-only use and tightening checks on ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
The health ministry warns that GLP-1 drugs for Type 2 Diabetes and obesity should only be taken under medical supervision due ...
India's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are ...
Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, has favorable effects on glycemic control and body weight. The effects ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes using tirzepatide had a 20% lower risk for major adverse CV events than those using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results